Early contrast enhancement of the liver: exact description of subphases using MRI

Magnetic Resonance Imaging

Volumn 27, Issue 6, 2009, Pages 792-800

  Goncalves Neto, Jose A ^a   Altun, Ersan ^a   Vaidean, Georgeta ^b   Elazzazi, Mohamed ^a   Troy, Jeffrey ^a   Ramachandran, Sudha ^a   Semelka, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Early enhancement; Liver; MRI; Phase

Indexed keywords

GADOBENATE DIMEGLUMINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; CHILD; CONTRAST ENHANCEMENT; FEMALE; HEPATIC ARTERY; HUMAN; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREATITIS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SPLENIC VEIN; STATISTICAL ANALYSIS;

ABDOMEN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VISCERA; YOUNG ADULT;

EID: 67349136024     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.11.003     Document Type: Article

References (22)

1. Earls J.P., Rofsky N.M., DeCorato D.R., Krinsky G.A., and Weinreb J.C. Hepatic-arterial phase dynamic gadolinium-enhanced MR imaging: optimization with a test examination and a power injector. Radiology 202 (1997) 268-273
2. Willatt J.M., Hussain H.K., Adusumilli S., and Marrero J.A. MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247 (2008) 311-330
3. Sultana S., Awai K., Nakayama Y., et al. Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 243 (2007) 140-147
4. Lee K.H.Y., O'Malley M.E., Haider M.A., and Hanbidge A. Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol 182 (2004) 643-649
5. Kanematsu M., Semelka R.C., Matsuo M., et al. Gadolinium-enhanced MR imaging of the liver: optimizing imaging delay for hepatic arterial and portal venous phases-a prospective randomized study in patients with chronic liver damage. Radiology 225 (2002) 407-415
6. Kim M.J., Choi J.Y., Lim J.S., et al. Optimal scan window for detection of hypervascular hepatocellular carcinomas during MDCT examination. AJR Am J Roentgenol 187 (2006) 198-206
7. Mori K., Yoshioka H., Takahashi N., et al. Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: comparison of the diagnostic accuracy among the early, middle, late and whole triple arterial phase imaging. AJR Am J Roentgenol 184 (2005) 63-69
8. Ito K., Fujita T., Shimizu A., et al. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions. AJR Am J Roentgenol 183 (2004) 699-705
9. Ichikawa T., Kitamura T., Nakajima H., et al. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver?. AJR Am J Roentgenol 179 (2002) 751-758
10. Ramalho M., Altun E., Heredia V., Zapparoli M., and Semelka R.C. Liver MR imaging: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15 (2007) 321-347
11. Semelka R.C., Martin D.R., and Balci N.C. Magnetic resonance imaging of the liver: how I do it. J Gastroenterol Hepatol 21 (2006) 632-637
12. Mirowitz S.A., Gutierrez E., Lee J.K.T., Brown J.J., and Heiken J.P. Normal abdominal enhancement patterns with dynamic gadolinium-enhanced MR imaging. Radiology 180 (1991) 637-640
13. Chu L.L., Joe B.N., Westphalen A.C.A., Webb E.M., Coakley F.V., and Yeh B.M. Patient-specific time to peak abdominal organ enhancement varies with time to peak aortic enhancement at MR imaging. Radiology 245 (2007) 779-787
14. Kanematsu M., Goshima S., Kondo H., et al. Double hepatic arterial phase MRI of the liver with switching of reversed centric and centric k-space reordering. AJR Am J Roentgenol 187 (2006) 464-472
15. Danet I.M., Semelka R.C., Leonardou P., et al. Spectrum of MRI appearances of untreated metastases of the liver. AJR Am J Roentgenol 181 (2003) 809-817
16. Danet I.M., Semelka R.C., Nagase L.L., Woosley J.T., Leonardou P., and Armao D. Liver metastases from pancreatic adenocarcinoma: MR imaging characteristics. J Magn Reson Imaging 18 (2003) 181-188
17. Altun E., Semelka R.C., Dale B.M., and Elias Jr. J. Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla. J Magn Reson Imaging 27 (2008) 1146-1154
18. Braga L., Semelka R.C., Pietrobon R., Martin D., de Barros N., and Guller U. Does hypervascularity of liver metastases as detected on MRI predict disease progression in breast cancer patients?. AJR Am J Roentgenol 182 (2004) 1207-1213
19. Kettritz U., Warshauer D.W., Brown E.D., Schlund J.F., Eisenberg L.B., and Semelka R.C. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Eur Radiol 6 (1996) 14-18
20. Semelka R.C., Shoenut J.P., Kroeker M.A., and Micflikier A.B. Chronic pancreatitis: MR imaging features before and after administration of gadopentate dimeglumine. J Magn Reson Imaging 6 (1993) 79-82
21. Hamed M.M., Hamm B., Ibrahim M.E., Taupitz M., and Mahfouz A.E. Dynamic MR imaging of the abdomen with gadopentetate dimeglumine: normal enhancement patterns of the liver, spleen, stomach, and pancreas. AJR Am J Roentgenol 158 (1992) 303-307
22. Semelka R.C., Shoenut J.P., Lawrence P.H., Greenberg H.M., Madden T.P., and Kroeker M.A. Spleen: dynamic enhancement patterns on gradient-echo MR images enhanced with gadopentetate dimeglumine. Radiology 185 (1992) 479-482